5-Hydroxytryptamine3 receptor antagonism modulates a noxious visceral pseudoaffective reflex

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Physiology

Background:

• The 5-Hydroxytryptamine (5-HT) system, particularly 5-HT3 receptors, is implicated in pain pathways.
• Understanding the role of specific 5-HT receptor subtypes in visceral pain modulation is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the effects of various 5-HT receptor agonists and antagonists on a cardiovascular reflex evoked by colorectal distension in rats.
• To determine the relative efficacy and potential site of action of different 5-HT3 receptor antagonists.

Main Methods:

• Intravenous and intrathecal administration of 5-HT receptor agonists and antagonists (methiothepin, ketanserin, ondansetron, granisetron) in anesthetized rats.
• Measurement of cardiovascular depressor responses evoked by acute noxious colorectal distension.
• Dose-effect analysis and ID50 estimation for active antagonists.
• Intrathecal administration to assess spinal cord involvement.

Main Results:

• Granisetron and ondansetron dose-dependently inhibited the depressor response, with granisetron exhibiting significantly higher potency (ID50 = 0.4 µg/kg) compared to ondansetron (ID50 = 36.7 µg/kg).
• Methiothepin caused transient blockade, while ketanserin was ineffective.
• Intrathecal granisetron blocked the depressor response, indicating a spinal site of action.
• 5-HT receptor agonists did not facilitate depressor responses but 8-OH DPAT facilitated pressor responses.

Conclusions:

• 5-HT3-like receptors play a role in modulating depressor cardiovascular responses to visceral pain.
• Different 5-HT3 receptor antagonists exhibit varying potencies, suggesting they are not equi-effective in this context.
• The spinal cord is likely involved in the action of 5-HT3 receptor antagonists on visceral pain pathways.